CLS Blue Sky Blog

ISS Offers a COVID-19 Update: Investor Related Class Actions

In March 2020, as the Coronavirus pandemic started to spread across the U.S. and wreak volatility in the stock market, securities class action complaints started to follow. Not surprisingly, U.S.-based litigation often follows wild stock market fluctuations as investors look to recover lost assets.

The very first COVID-19 related class action was filed on March 12, 2020 in USDC Florida (Southern) against Norwegian Cruise Line Holdings. Shareholders alleged the Miami-based company with deceptive sales tactics and misleading updates to the investor community related to its business and operations.

Since the Norwegian complaint was filed, in the last 14 months, ISS Securities Class Action Services has tracked a total of 37 COVID-19 related cases. This includes a wide array of allegations against companies in many different industries… including (but not limited to) pharmaceutical, biotechnology, travel, financial, technology, real estate, energy, and food services.

A few other examples of the 37 COVID-19 related investor allegations include a failure to disclose the truth that vaccine clinical trials had suffered manufacturing errors (AstraZeneca); false and misleading information about a vaccine candidate as executives suspiciously timed stock trades (Vaxart); and failure to implement proper pandemic-related safety protocols for plant workers which led to misleading shareholders about lower production and revenue shortfalls (Tyson Foods).

The following key statistics include COVID-19 related investor class actions filed within the United States from March 12, 2020 – April 30, 2021:

Based upon the above activity, it is clear shareholders are paying very close attention to the actions of publicly traded companies during the Coronavirus pandemic. ISS Securities Class Action Services will continue to monitor each of the remaining 30 active cases, along with any future investor complaints… and share all relevant details with its clients and the investment community. Only time will tell if the above noted COVID-19 allegations correlate to investor settlement recoveries.

This post comes to us from Institutional Shareholder Services. It is based on the firm’s memorandum, “COVID-19 Update: Investor Related Class Actions,” dated May 18, 2021.

Exit mobile version